Achillion Pharmaceuticals, Inc. (ACHN): Are Hedge Funds Right About This Stock?
To most stock holders, hedge funds are seen as underperforming, old financial tools of years past.
Clovis Oncology Inc. (CLVS)
Market is closed
News
- First
- << Previous
- 61 - 66
Do Hedge Funds and Insiders Love Clovis Oncology Inc (CLVS)?
Clovis Oncology Inc (NASDAQ:CLVS) was in 11 hedge funds' portfolio at the end of the first quarter of 2013. CLVS has seen an increase in hedge fund interest of late.
Is Clovis Oncology Inc (CLVS) Going to Burn These Hedge Funds?
Is Clovis Oncology Inc (NASDAQ:CLVS) the right investment to pursue these days? The best stock pickers are taking a pessimistic view.
CAPScall of the Week: Clovis Oncology Inc (CLVS)
For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.
3 Humongous Health-Care Stocks Last Week: Orexigen Therapeutics, Inc. (OREX), Optimer Pharmaceuticals, Inc. (OPTR)
While the overall market seemed to be deciding this week whether to keep the rally going or take a break, several stocks in the world of health care left no doubt.
Celgene Corporation (CELG)'s New Acquisition -- of Celgene
Celgene Corporation (NASDAQ:CELG) announced on Wednesday a $600 million deal to buy a stake in a growing biotech with several successful products on the market and a strong pipeline.
- First
- << Previous
- 61 - 66
Billionaire Hedge Funds
